PharmaEstica Manufacturing OÜ

Active Registry code 10264929 OÜ Pringi küla Registered 19 Sep 1997
Compare

PharmaEstica Manufacturing OÜ is a OÜ based in Pringi küla, registry code 10264929, status: active. Main activity: Manufacture of pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €318 394 with 16 employees.

Turnover
318 394 €
↓ 36.8% vs Q2 2026
State taxes
77 518 €
↓ 7.1% vs Q2 2026
Labour taxes
76 990 €
↓ 11.0% vs Q2 2026
Employees
16
±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Turnover · Q3 2026 318 394 €
    industry median 234 187 € · companies in the industry: 12
  • Labour taxes per employee 4 812 €
    industry median 4 573 € · companies in the industry: 12
  • Revenue · 2025 1.7 mn €
    industry median 48 003 € · companies in the industry: 19
  • Net profit margin · 2025 -12.6 %
    industry median 9.8 % · companies in the industry: 15

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € thousand Q3 2026: 318 394 € · −36.8% vs Q2 2026 · industry median 234 187 € · above 53% of the industry
02004006008001 000Q4 2023 Company: 271 860 € Industry median: 102 827 €Q4·23Q1 2024 Company: 310 932 € Industry median: 160 070 €Q2 2024 Company: 815 458 € Industry median: 216 097 €Q2·24Q3 2024 Company: 334 212 € Industry median: 261 493 €Q4 2024 Company: 413 848 € Industry median: 198 576 €Q4·24Q1 2025 Company: 524 995 € Industry median: 231 372 €Q2 2025 Company: 379 869 € Industry median: 292 853 €Q2·25Q3 2025 Company: 301 828 € Industry median: 423 731 €Q4 2025 Company: 594 386 € Industry median: 410 601 €Q4·25Q1 2026 Company: 465 621 € Industry median: 375 496 €Q2 2026 Company: 503 502 € Industry median: 198 786 €Q2·26Q3 2026 Company: 318 394 € Industry median: 234 187 €Q3·260200400600Q4 2024 Company: 413 848 € Industry median: 198 576 €Q1 2025 Company: 524 995 € Industry median: 231 372 €Q1·25Q2 2025 Company: 379 869 € Industry median: 292 853 €Q3 2025 Company: 301 828 € Industry median: 423 731 €Q3·25Q4 2025 Company: 594 386 € Industry median: 410 601 €Q1 2026 Company: 465 621 € Industry median: 375 496 €Q1·26Q2 2026 Company: 503 502 € Industry median: 198 786 €Q3 2026 Company: 318 394 € Industry median: 234 187 €Q3·26
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q3 2026: 4 812 € · −11.0% vs Q2 2026 · industry median 4 573 € · above 55% of the industry
02 0004 0006 000Q4 2023 Company: 2 765 € Industry median: 3 627 €Q4·23Q1 2024 Company: 2 402 € Industry median: 3 668 €Q2 2024 Company: 3 627 € Industry median: 3 706 €Q2·24Q3 2024 Company: 3 436 € Industry median: 3 971 €Q4 2024 Company: 1 390 € Industry median: 3 921 €Q4·24Q1 2025 Company: 2 474 € Industry median: 4 259 €Q2 2025 Company: 3 739 € Industry median: 3 971 €Q2·25Q3 2025 Company: 2 347 € Industry median: 4 236 €Q4 2025 Company: 4 058 € Industry median: 4 504 €Q4·25Q1 2026 Company: 1 422 € Industry median: 4 205 €Q2 2026 Company: 5 406 € Industry median: 4 757 €Q2·26Q3 2026 Company: 4 812 € Industry median: 4 573 €Q3·2602 0004 0006 000Q4 2024 Company: 1 390 € Industry median: 3 921 €Q1 2025 Company: 2 474 € Industry median: 4 259 €Q1·25Q2 2025 Company: 3 739 € Industry median: 3 971 €Q3 2025 Company: 2 347 € Industry median: 4 236 €Q3·25Q4 2025 Company: 4 058 € Industry median: 4 504 €Q1 2026 Company: 1 422 € Industry median: 4 205 €Q1·26Q2 2026 Company: 5 406 € Industry median: 4 757 €Q3 2026 Company: 4 812 € Industry median: 4 573 €Q3·26
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 16 · +0.0% vs Q2 2026
0102030Q4 2023 Company: 25Q4·23Q1 2024 Company: 25Q2 2024 Company: 26Q2·24Q3 2024 Company: 24Q4 2024 Company: 25Q4·24Q1 2025 Company: 26Q2 2025 Company: 23Q2·25Q3 2025 Company: 23Q4 2025 Company: 24Q4·25Q1 2026 Company: 17Q2 2026 Company: 16Q2·26Q3 2026 Company: 16Q3·260102030Q4 2024 Company: 25Q1 2025 Company: 26Q1·25Q2 2025 Company: 23Q3 2025 Company: 23Q3·25Q4 2025 Company: 24Q1 2026 Company: 17Q1·26Q2 2026 Company: 16Q3 2026 Company: 16Q3·26
State taxes, € Q3 2026: 77 518 € · −7.1% vs Q2 2026
020 00040 00060 00080 000100 000Q4 2023 Company: 66 124 €Q4·23Q1 2024 Company: 56 533 €Q2 2024 Company: 90 864 €Q2·24Q3 2024 Company: 78 238 €Q4 2024 Company: 33 719 €Q4·24Q1 2025 Company: 61 009 €Q2 2025 Company: 81 550 €Q2·25Q3 2025 Company: 52 567 €Q4 2025 Company: 93 271 €Q4·25Q1 2026 Company: 23 224 €Q2 2026 Company: 83 462 €Q2·26Q3 2026 Company: 77 518 €Q3·26020 00040 00060 00080 000100 000Q4 2024 Company: 33 719 €Q1 2025 Company: 61 009 €Q1·25Q2 2025 Company: 81 550 €Q3 2025 Company: 52 567 €Q3·25Q4 2025 Company: 93 271 €Q1 2026 Company: 23 224 €Q1·26Q2 2026 Company: 83 462 €Q3 2026 Company: 77 518 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 318 394 77 518 76 990 16
Q2 2026 503 502 83 462 86 498 16
Q1 2026 465 621 23 224 24 172 17
Q4 2025 594 386 93 271 97 397 24
Q3 2025 301 828 52 567 53 984 23
Q2 2025 379 869 81 550 86 005 23
Q1 2025 524 995 61 009 64 324 26
Q4 2024 413 848 33 719 34 749 25
Q3 2024 334 212 78 238 82 473 24
Q2 2024 815 458 90 864 94 293 26
Q1 2024 310 932 56 533 60 039 25
Q4 2023 271 860 66 124 69 116 25
Q3 2023 169 989 83 784 88 170 23
Q2 2023 174 897 86 063 88 652 26
Q1 2023 219 458 54 363 57 733 26
Q4 2022 423 664 67 364 70 020 28
Q3 2022 315 567 75 013 79 033 27
Q2 2022 209 959 67 254 70 032 27
Q1 2022 41 100 57 154 61 281 26
Labour taxes per employee per month
1 604 €
Turnover per employee in the quarter
19 900 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025
Revenue, € thousand 2025: 1 742 556 € · +14.9% vs 2024 · industry median 48 003 € · above 74% of the industry
05001 0001 5002 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 234 658 € Industry median: 28 809 €20192020 Company: 563 049 € Industry median: 25 207 €20202021 Company: 772 244 € Industry median: 11 877 €20212022 Company: 830 528 € Industry median: 4 897 €20222023 Company: 728 423 € Industry median: 3 851 €20232024 Company: 1 517 157 € Industry median: 25 284 €20242025 Company: 1 742 556 € Industry median: 48 003 €202505001 0001 5002 0002018 Company: — Industry median: —2019 Company: 234 658 € Industry median: 28 809 €20192020 Company: 563 049 € Industry median: 25 207 €2021 Company: 772 244 € Industry median: 11 877 €20212022 Company: 830 528 € Industry median: 4 897 €2023 Company: 728 423 € Industry median: 3 851 €20232024 Company: 1 517 157 € Industry median: 25 284 €2025 Company: 1 742 556 € Industry median: 48 003 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: -219 100 € · +58.5% vs 2024 · industry median 676 € · above 13% of the industry
-2 000-1 00001 0002 0003 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 2 505 223 € Industry median: 2 812 €20192020 Company: -1 752 777 € Industry median: 97 €20202021 Company: -1 372 918 € Industry median: 0 €20212022 Company: -1 623 296 € Industry median: 0 €20222023 Company: -1 071 673 € Industry median: 0 €20232024 Company: -527 604 € Industry median: 0 €20242025 Company: -219 100 € Industry median: 676 €2025-2 000-1 00001 0002 0003 0002018 Company: — Industry median: —2019 Company: 2 505 223 € Industry median: 2 812 €20192020 Company: -1 752 777 € Industry median: 97 €2021 Company: -1 372 918 € Industry median: 0 €20212022 Company: -1 623 296 € Industry median: 0 €2023 Company: -1 071 673 € Industry median: 0 €20232024 Company: -527 604 € Industry median: 0 €2025 Company: -219 100 € Industry median: 676 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: -12.6 % · +22.2 pp vs the year before · industry median 9.8 % · above 29% of the industry
-50005001 0001 5002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 1 067.6 % Industry median: 10.2 %20192020 Company: -311.3 % Industry median: 7.1 %20202021 Company: -177.8 % Industry median: 1.4 %20212022 Company: -195.5 % Industry median: -1.9 %20222023 Company: -147.1 % Industry median: 4.4 %20232024 Company: -34.8 % Industry median: 1.2 %20242025 Company: -12.6 % Industry median: 9.8 %2025-50005001 0001 5002018 Company: — Industry median: —2019 Company: 1 067.6 % Industry median: 10.2 %20192020 Company: -311.3 % Industry median: 7.1 %2021 Company: -177.8 % Industry median: 1.4 %20212022 Company: -195.5 % Industry median: -1.9 %2023 Company: -147.1 % Industry median: 4.4 %20232024 Company: -34.8 % Industry median: 1.2 %2025 Company: -12.6 % Industry median: 9.8 %2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 1 954 063 € · −13.4% vs 2024
01 0002 0003 0004 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 3 226 966 €20192020 Company: 3 281 893 €20202021 Company: 2 922 620 €20212022 Company: 2 700 600 €20222023 Company: 2 449 555 €20232024 Company: 2 256 458 €20242025 Company: 1 954 063 €202501 0002 0003 0004 0002018 Company: —2019 Company: 3 226 966 €20192020 Company: 3 281 893 €2021 Company: 2 922 620 €20212022 Company: 2 700 600 €2023 Company: 2 449 555 €20232024 Company: 2 256 458 €2025 Company: 1 954 063 €2025
Equity, € thousand 2025: -1 048 229 € · −26.4% vs 2024
-4 000-2 00002 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 1 983 143 €20192020 Company: 252 390 €20202021 Company: -1 120 528 €20212022 Company: -2 743 824 €20222023 Company: -3 815 497 €20232024 Company: -829 129 €20242025 Company: -1 048 229 €2025-4 000-2 00002 0002018 Company: —2019 Company: 1 983 143 €20192020 Company: 252 390 €2021 Company: -1 120 528 €20212022 Company: -2 743 824 €2023 Company: -3 815 497 €20232024 Company: -829 129 €2025 Company: -1 048 229 €2025
Employees 2025: 25 · +0.0% vs 2024 · industry median 28 · above 45% of the industry
0102030402016 Company: 30 Industry median: —20162017 Company: 30 Industry median: —20172018 Company: 27 Industry median: —20182019 Company: 30 Industry median: 3420192020 Company: 34 Industry median: 32.520202021 Company: 32 Industry median: —20212022 Company: 27 Industry median: —20222023 Company: 25 Industry median: 2520232024 Company: 25 Industry median: 3220242025 Company: 25 Industry median: 2820250102030402018 Company: 27 Industry median: —2019 Company: 30 Industry median: 3420192020 Company: 34 Industry median: 32.52021 Company: 32 Industry median: —20212022 Company: 27 Industry median: —2023 Company: 25 Industry median: 2520232024 Company: 25 Industry median: 322025 Company: 25 Industry median: 282025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 1 742 556 -219 100 795 394 1 954 063 -1 048 229 25
2024 1 517 157 -527 604 791 971 2 256 458 -829 129 25
2023 728 423 -1 071 673 772 509 2 449 555 -3 815 497 25
2022 830 528 -1 623 296 768 752 2 700 600 -2 743 824 27
2021 772 244 -1 372 918 932 539 2 922 620 -1 120 528 32
2020 563 049 -1 752 777 1 081 274 3 281 893 252 390 34
2019 234 658 2 505 223 615 945 3 226 966 1 983 143 30
2018 — — — — — 27
2017 — — — — — 30
2016 — — — — — 30
2015 — — — — — 30
2014 — — — — — 31
2013 — — — — — 30
2012 — — — — — 30
2011 — — — — — 25
2010 — — — — — 21
2009 — — — — — 9
2008 — — — — — 10
2007 — — — — — 8
2006 — — — — — 7
2005 — — — — — 8
2004 — — — — — 10
2003 — — — — — 8
2002 — — — — — 8

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
-12.6 %
Net profit / revenue
Return on assets (ROA)
-11.2 %
Net profit / assets
Equity ratio
-53.6 %
Equity / assets
Debt ratio
153.6 %
Liabilities / assets
Current ratio
0.12
Current assets / current liabilities
Revenue per employee
69 702 €
Revenue / average full-time employees
Labour cost per employee per month
2 651 €
Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 14 Sep 2026 Company’s own · audited e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 19 Aug 2025 Company’s own · audited e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 13 Jul 2024 Company’s own · audited e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 28 Aug 2023 Company’s own · audited e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 12 Jul 2022 Company’s own · audited e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 7 Jul 2021 Company’s own · audited e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 20 Oct 2020 Company’s own · audited e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

No other persons.

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 21201Manufacture of pharmaceutical preparations Main
  • 74991All other professional, scientific and technical activities n.e.c.
  • 77401Leasing of intellectual property and similar products, except copyrighted works
  • 77521Intermediation service activities for rental and leasing of other tangible goods and non-financial intangible assets
Rulings
Number, date Title Deadline State Document
Ä 10017358 / M14
18 Jul 2026
Warning of a fine: annual report not filed 17 Aug 2026 Deficiencies eliminated
14 Sep 2026
PDF
Ä 10017358 / 41
4 Nov 2025
Amendment entry In force
4 Nov 2025
PDF
Ä 10017358 / M13
22 Aug 2025
Fine for not filing the report 9 Sep 2025 In force
9 Sep 2025
PDF
Ä 10017358 / M12
13 Jul 2025
Warning of a fine: annual report not filed 13 Aug 2025 In force
14 Jul 2025
PDF
Ä 10017358 / 40
16 Jun 2025
Amendment entry In force
16 Jun 2025
PDF
Ä 10017358 / 39
5 Jun 2025
Amendment entry In force
5 Jun 2025
PDF
Ä 10017358 / M11
28 May 2025
Ruling to eliminate deficiencies 29 Jun 2025 Deficiencies eliminated
6 Jun 2025
PDF
Ä 10017358 / 38
3 Feb 2025
Amendment entry In force
3 Feb 2025
PDF
Ä 10017358 / M10
31 Jan 2025
Procedural ruling 14 Feb 2025 Deficiencies eliminated
3 Feb 2025
PDF
Ä 10017358 / 37
14 Nov 2024
Amendment entry In force
14 Nov 2024
PDF
Ä 10017358 / M9
6 Jul 2024
Warning of a fine: annual report not filed 5 Aug 2024 Deficiencies eliminated
15 Jul 2024
PDF
Ä 10017358 / 36
14 Mar 2024
Amendment entry In force
14 Mar 2024
PDF
Ä 10017358 / 35
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 10017358 / M8
23 Aug 2023
Warning of a fine: annual report not filed 22 Sep 2023 Deficiencies eliminated
29 Aug 2023
PDF
Ä 10017358 / 34
27 May 2022
Amendment entry In force
27 May 2022
PDF
Ä 10017358 / 33
1 Oct 2019
Amendment entry In force
1 Oct 2019
PDF
Ä 10017358 / 32
1 Oct 2019
Amendment entry In force
1 Oct 2019
PDF
Ä 10017358 / 31
2 Apr 2019
Amendment entry In force
2 Apr 2019
PDF
Ä 10017358 / 30
12 Mar 2019
Amendment entry In force
12 Mar 2019
PDF
Ä 10017358 / 29
12 Feb 2019
Amendment entry In force
12 Feb 2019
PDF
Ä 10017358 / 28
28 Aug 2018
Amendment entry In force
28 Aug 2018
PDF
Ä 10017358 / 27
29 May 2018
Amendment entry In force
29 May 2018
PDF
Ä 10017358 / M7
25 Apr 2018
Warning of deletion from the register: annual report not filed 25 Oct 2018 Deficiencies eliminated
29 May 2018
PDF
Ä 10017358 / 26
16 Jan 2018
Amendment entry In force
16 Jan 2018
PDF
Ä 10017358 / 25
7 Nov 2017
Amendment entry In force
7 Nov 2017
PDF
Ä 10017358 / 24
31 May 2017
Amendment entry In force
31 May 2017
PDF
Ä 10017358 / 23
13 Apr 2017
Amendment entry In force
13 Apr 2017
PDF
Ä 10017358 / 22
9 Mar 2017
Amendment entry In force
9 Mar 2017
PDF
Ä 10017358 / M6
3 Mar 2017
Ruling to eliminate deficiencies 18 Mar 2017 Deficiencies eliminated
6 Mar 2017
PDF
Ä 10017358 / 21
17 Feb 2017
Amendment entry In force
17 Feb 2017
PDF
Ä 10017358 / 20
13 Nov 2015
Amendment entry In force
13 Nov 2015
PDF
Ä 10017358 / 19
10 Nov 2015
Amendment entry In force
10 Nov 2015
PDF
Ä 10017358 / M5
4 Nov 2015
Ruling to eliminate deficiencies 19 Nov 2015 Deficiencies eliminated
13 Nov 2015
PDF
Ä 10017358 / 18
27 Nov 2012
Amendment entry In force
27 Nov 2012
PDF
Ä 10017358 / M4
14 Nov 2012
Ruling to eliminate deficiencies 10 Dec 2012 In force
14 Nov 2012
PDF
Ä 10017358 / 17
2 Jun 2011
Amendment entry In force
2 Jun 2011
PDF
Ä 10017358 / 16
28 Jun 2010
Deletion of activities from the registry card In force
28 Jun 2010
PDF
Ä 17358 / 15
3 Feb 2010
Amendment entry In force
3 Feb 2010
PDF
Ä 17358 / 14
27 Jan 2010
Amendment entry In force
27 Jan 2010
PDF
K 103125 / M1
16 Dec 2009
Ruling to eliminate deficiencies 18 Jan 2010 In force
16 Dec 2009
PDF
K 103125 / 6
16 Dec 2009
Commercial pledge deleted In force
16 Dec 2009
PDF
K 103125 / 5
16 Dec 2009
Commercial pledge deleted In force
16 Dec 2009
PDF
K 103125 / 4
16 Dec 2009
Commercial pledge deleted In force
16 Dec 2009
PDF
Ä 17358 / 13
13 Nov 2009
Amendment entry In force
13 Nov 2009
PDF
Ä 17358 / 12
18 Mar 2009
Amendment under Commercial Code § 525 (2) In force
18 Mar 2009
PDF
K 103125 / 3
24 Sep 2008
Commercial pledge entered In force
24 Sep 2008
PDF
K 103125 / 2
27 Dec 2006
Commercial pledge entered In force
27 Dec 2006
PDF
K 103125
23 Oct 2006
Commercial pledge entered In force
23 Oct 2006
PDF
Ä 17358 / 11
28 Mar 2005
Amendment entry In force PDF
Ä 17358 / 10
13 Nov 2003
Entry decision on the register’s own initiative In force PDF
Ä 17358 / 9
5 Nov 2003
Amendment entry In force PDF
Ä 17358 / 8
12 Aug 2003
Amendment entry In force PDF
Ä 17358 / 7
27 Jan 2003
Negative entry decision In force PDF
Ä 17358 / 6
12 Dec 2002
Entry decision on the register’s own initiative In force PDF
Ä 17358 / 5
12 Dec 2002
Published amendment entry In force PDF
Ä 17358 / M3
23 Sep 2002
Ruling to eliminate deficiencies (to be served) 10 Jan 2003 In force PDF
Ä 17358 / M2
3 Jul 2002
Ruling to eliminate deficiencies (to be served) 10 Sep 2002 In force PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data